Observational studyDiabetes, obesity & metabolism2024

Long-term safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study.

Yu-Nan Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.